Good Samaritan Hospital of Suffern Drug Abuse Treatment Unit/Detox
-
Services:
- Naloxone and overdose education
- Outcome follow-up after discharge
- Aftercare/continuing care
- Discharge Planning
- Sign language services for the deaf and hard of hearing
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Smoking not permitted
- Hospital inpatient treatment
- Hospital inpatient/24-hour hospital inpatient
- Hospital inpatient detoxification
- General Hospital (including VA hospital)
- Vaping not permitted
- Male
- Female
- Buprenorphine used in Treatment
- Methadone used in Treatment
- Comprehensive substance use assessment
- Screening for tobacco use
- Complete medical history/physical exam
- Screening for substance use
- Screening for mental disorders
- Outreach to persons in the community
- Comprehensive mental health assessment
- Individual counseling
- Substance use disorder education
- Group counseling
- Family counseling
- Smoking/vaping/tobacco cessation counseling
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- No formal relationship with prescribing entity
- TB screening
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- HIV testing
- STD testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis B (HBV)
- Metabolic syndrome monitoring
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Substance use treatment
- Substance use disorder counseling
- 12-step facilitation
- Cognitive behavioral therapy
- Trauma-related counseling
- Motivational interviewing
- Brief intervention
- Relapse prevention
- Assistance with obtaining social services
- Recovery coach
- Mentoring/peer support
- Self-help groups
- The Joint Commission
- State department of health
- Drug Enforcement Agency (DEA)
- State Substance use treatment agency
- Hospital licensing authority
- SAMHSA certification for opioid treatment program (OTP)
- Adults
- Young Adults
- Private non-profit organization
- Buprenorphine detoxification
- Federally-certified Opioid Treatment Program
- Accepts clients using MAT but prescribed elsewhere
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Lofexidine or Clonidine detoxification
- Methadone detoxification
- No formal relationship with prescribing entity
- Alcohol Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Benzodiazepines Detoxification
- Medicaid
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- Federal military insurance (e.g., TRICARE)
- Private health insurance
- Medicare
- Medication for mental disorders
- Non-nicotine smoking/tobacco cessation
- Methadone
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Nicotine replacement
- Clonidine
- Medications for HIV treatment
- Case management service
- Mental health services
- Suicide prevention services
- Early intervention for HIV
- Domestic violence services, including family or partner
Transitional Services
Language Services
Type of Alcohol Use Disorder Treatment
Facility Smoking Policy
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Hospitals
Facility Vaping Policy
Gender Accepted
Opioid Medications used in Treatment
Assessment/Pre-treatment
Education and Counseling Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Testing
Type of Care
Treatment Approaches
Recovery Support Services
License/Certification/Accreditation
Age Groups Accepted
Facility Operation (e.g., Private, Public)
Type of Opioid Treatment
External Opioid Medications Source
Detoxification (medical withdrawal) Services
Payment/Insurance/Funding Accepted
Pharmacotherapies
Ancillary Services